Using innovation to accelerate & optimize your drug manufacturing scale-up strategy

Explore how AI-enabled QbD represents a game-changing approach for pharmaceutical manufacturing

The pharmaceutical industry faces unprecedented challenges in bringing life-saving drugs to market while maintaining the highest standards of quality, compliance, and operational efficiency. As companies navigate the complex journey from pre-market development to post-market manufacturing, traditional approaches to drug manufacturing scale-up are proving insufficient to meet evolving demands. This webinar explores how innovative technologies and strategic approaches are transforming the pharmaceutical manufacturing landscape, enabling companies to accelerate their scale-up processes while optimizing quality outcomes and achieving critical success metrics including operational efficiency, regulatory compliance, supply chain resilience, and enhanced manufacturing experience.

Attendees will discover innovative focus areas for value delivery, including how to achieve faster scale-up and transfer from development to manufacturing, reducing time-to-market while maintaining quality standards. We'll examine strategies for achieving faster batch release through reduced cycle times and explore proactive quality capabilities that can help to significantly reduce defects. The session will address key challenges in ensuring continuity of supply and operations and optimizing product integrity and release efficiencies.

We'll explore how AI-enabled Quality by Design (QbD) represents a game-changing approach, with the maturity of artificial intelligence unlocking unprecedented possibilities for pharmaceutical manufacturing. The session will delve into practical QbD implementation through continuous process verification and process characterization, ultimately guiding organizations toward achieving 'golden batch' conditions that represent the pinnacle of manufacturing excellence. Finally, we'll discuss the digital transformation roadmap for life sciences manufacturing and quality management, providing insights into what's next for the industry's digital evolution.

Key learning objectives:

• Identify strategic value drivers: Understand the critical value drivers throughout the pharmaceutical product lifecycle and how to optimize outcomes including operational efficiency, compliance, resilience, and sustainability in manufacturing scale-up strategies
• Leverage AI-Enabled quality by design: Learn how artificial intelligence and digital technologies are revolutionizing Quality by Design approaches, enabling more efficient and effective drug manufacturing scale-up processes while maintaining regulatory compliance and product integrity
• Implement digital transformation strategies: Gain insights into digital focus areas for life sciences manufacturing and quality management, including advanced manufacturing techniques, supply chain optimization, and the future roadmap for digital transformation in pharmaceutical operations